ArticleEULAR rheumatology open2026
Building the future of patient-centred research: an EULAR PARE community of practice advancing patient research partner involvement in rheumatology.
Article in EULAR rheumatology open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: The European Alliance of Associations for Rheumatology (EULAR) supports patient involvement in research through its People with Arthritis and Rheumatism in Europe (PARE) network. Updated 2023 recommendations promote inclusion of Patient Research Partners (PRPs) in research; however, implementation remains inconsistent. Key challenges include unclear PRP roles, limited researcher preparedness, insufficient support, and a lack of systematic feedback on impact. We describe how the EULAR PARE community of practice used cocreation to develop practical, implementation-focused solutions. Methods: The 2024 EULAR PARE conference used a World Café format to explore stakeholder experiences and identify barriers to collaborative research. Building on these findings, the 2025 conference centred on 4 multistakeholder Hackathon workshops to codevelop solutions. Participant experience in 2025 was evaluated using the Patient Engagement In Research Scale (PEIRS-22). Results: The 2024 conference identified 4 priority challenges: unclear PRP roles, variation in uptake across Europe, limited researcher training, and uncertainty about PRP impact due to insufficient feedback. In 2025, Hackathons generated actionable outputs, including concepts for a PRP toolkit and role descriptions, profiles for national PRP coordinators and ambassadors, a Supporting Patient Research Collaboration hub, a draft researcher training course, and a framework for evaluating PRP involvement. Fifty-four participants (46% response rate) completed PEIRS-22; the mean score was 88, indicating high, meaningful engagement. Conclusions: From 2024 to 2025, the EULAR PARE community identified key challenges and translated them through Hackathon workshops into feasible solutions to strengthen collaborative research. The ongoing next steps will be to refine, pilot, and scale these solutions across Europe.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.